Scarica l'app Stockscreener
1.60
3.61%
-0.06
Dopo l'orario di chiusura:
1.59
-0.01
-0.63%
Precedente Chiudi:
$1.66
Aprire:
$1.7
Volume 24 ore:
1.88M
Relative Volume:
2.47
Capitalizzazione di mercato:
$147.01M
Reddito:
-
Utile/perdita netta:
$-30.15M
Rapporto P/E:
-1.7582
EPS:
-0.91
Flusso di cassa netto:
$-31.63M
1 W Prestazione:
+8.84%
1M Prestazione:
+50.94%
6M Prestazione:
+148.83%
1 anno Prestazione:
+32.23%
Intervallo 1D:
$1.57
$1.715
Intervallo di 1 settimana:
$1.40
$2.00
Portata 52W:
$0.49
$2.00
Context Therapeutics Inc Stock (CNTX) Company Profile
Nome
Context Therapeutics Inc
Settore
Industria
Telefono
267-225-7416
Indirizzo
2001 MARKET STREET, PHILADELPHIA
Confronta CNTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNTX
Context Therapeutics Inc
|
1.60 | 152.52M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-18 | Iniziato | Guggenheim | Buy |
| 2025-04-21 | Iniziato | William Blair | Outperform |
| 2025-01-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-11-25 | Iniziato | D. Boral Capital | Buy |
| 2024-05-16 | Iniziato | Piper Sandler | Overweight |
Context Therapeutics Inc Borsa (CNTX) Ultime notizie
Can Context Therapeutics Inc. stock hit record highs againWeekly Earnings Recap & Weekly Top Stock Performers List - ulpravda.ru
Will Theranexus Société Anonyme (3VG) stock beat value stocks2025 Big Picture & Proven Capital Preservation Methods - ulpravda.ru
Why Context Therapeutics Inc. stock is trending among retail tradersJuly 2025 Rallies & Weekly Breakout Watchlists - ulpravda.ru
Why Context Therapeutics Inc. stock could benefit from AI revolutionJuly 2025 Sentiment & Daily Profit Maximizing Tips - ulpravda.ru
Will Enliven Therapeutics Inc. stock see insider buyingWeekly Stock Report & AI Forecasted Stock Moves - ulpravda.ru
Context Therapeutics Highlights T Cell Engager Pipeline Strategy - TipRanks
Context Therapeutics Inc Updates Corporate Presentation on T Cell Engagers - TradingView — Track All Markets
Why Context Therapeutics Inc. stock remains on buy listsGrowth Stock Opportunities & Fast Profit Trading Tips - ulpravda.ru
Pittsburgh Post-GazetteContext Therapeutics Inc.Common Stock (Nasdaq:CNTX) Price Chart - FinancialContent
ALNA pre-market +3.16% on 252,311,606 shares 06 Jan 2026: check catalysts - Meyka
After-Hours Biotech Rally: Alumis, Genelux, Bright Minds, Context Therapeutics Post Big Gains - Nasdaq
Wondering what's happening in today's after-hours session? - Chartmill
Kartoon Studios (NYSE: TOON) Expansion Fuels 2026-2027 UpsideDVLT, UFG, VRME, ARBE More Inside - openPR.com
Kartoon Studios (NYSE: TOON) Expansion Fuels 2026-2027 Upside – DVLT, UFG, VRME, ARBE More Inside - FinancialContent
Uni-Fuels Holdings Limited (UFG) Stock, Price, News, Quotes, Forecast and Insights - MSN
Akero Therapeutics, Inc. (AKRO) Stock Analysis: Potential 3.39% Upside In Biotech Innovation - DirectorsTalk Interviews
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
MACD Signals Flash Warning for CRP Risk Management Limited StockAnalyst Upgrades & High Yield Portfolio Growth - bollywoodhelpline.com
Raconteur Global Resources Limited Inches Toward Key Resistance — Will It BreakChart Pattern Recognition & Small Budget Wealth Building - bollywoodhelpline.com
BDH Industries Limited Building a Base Near SupportHead and Shoulders Patterns & High Profit Trading Alerts - bollywoodhelpline.com
MACD Signals Flash Warning for Sagar Diamonds Limited StockEarnings Beat Highlights & Free Stock Price Trend Analysis - bollywoodhelpline.com
Jones Trading Initiates Coverage of Context Therapeutics (CNTX) with Buy Recommendation - Nasdaq
Context Therapeutics (NASDAQ:CNTX) Coverage Initiated by Analysts at Jones Trading - MarketBeat
This Blacksky Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Aug Reactions: Why Context Therapeutics Inc. stock could benefit from AI revolutionPortfolio Gains Report & AI Powered Market Entry Strategies - moha.gov.vn
Published on: 2025-12-21 00:47:49 - Улправда
Will Context Therapeutics Inc. stock benefit from automation2025 Fundamental Recap & Growth Focused Stock Reports - Улправда
Is Context Therapeutics Inc. stock a buy before product launchesJuly 2025 Technicals & Free Weekly Watchlist of Top Performers - Улправда
Bearish Setup: Will Calidi Biotherapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Levels & Weekly Stock Breakout Alerts - Улправда
Breakouts Watch: How Context Therapeutics Inc. stock compares to market leaders2025 Momentum Check & Community Verified Watchlist Alerts - Улправда
Context Therapeutics Earnings Notes - Trefis
Why Context Therapeutics Inc. stock is a must watch in 2025Trade Signal Summary & Weekly Stock Performance Updates - DonanımHaber
Context Therapeutics Inc. (NASDAQ:CNTX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
How Context Therapeutics Inc. stock compares to market leadersWeekly Gains Summary & Weekly Breakout Watchlists - Улправда
Can Forum Energy Technologies Inc. stock attract ESG capital inflowsWeekly Investment Summary & Technical Pattern Alert System - Улправда
Is ABR.PRD stock trading near support levelsWeekly Stock Analysis & Consistent Growth Stock Picks - Улправда
Context Therapeutics Inc. (NASDAQ:CNTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
SJVN Limited (533206) Stock Experiences Sudden DipMoving Average Strategies & Free Tremendous Portfolio Expansion - Bollywood Helpline
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards - GlobeNewswire
Context Therapeutics (NASDAQ:CNTX) Shares Up 8.7%What's Next? - MarketBeat
Context Therapeutics (NASDAQ:CNTX) Shares Up 8.7% – What’s Next? - Defense World
Oncotelic Therapeutics Study Reveals Context-Dependent Biomarker Significance in Liver and Pancreatic Cancers - citybuzz -
Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer - The Manila Times
Unpacking Q3 Earnings: CoStar (NASDAQ:CSGP) In The Context Of Other Data & Business Process Services Stocks - Yahoo Finance
Context Therapeutics Inc (CNTX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - setenews.com
Context Therapeutics Names Dr. Karen Smith as Interim Chief Medical Officer - MSN
Is Context Therapeutics Inc. stock attractive for growth ETFs2025 Volume Leaders & AI Powered Trade Plan Recommendations - Newser
Unpacking Q3 Earnings: Axon (NASDAQ:AXON) In The Context Of Other Aerospace and Defense Stocks - Yahoo Finance
CT-202, a tumor-selective pH-dependent Nectin-4/CD3 TCE - BioWorld MedTech
Context Therapeutics Inc. (NASDAQ:CNTX) Receives $5.40 Average Target Price from Brokerages - Defense World
Context Therapeutics Inc Azioni (CNTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):